They observed that BCAR4 expression was significantly correlated with poor OS (HR = 1.98, CI: [1.71–2.29]), p < 0.00001, and high expression levels of BCAR4 correlated with worse clinical stage, distant metastases, and lymph node metastasis [92]. Here, BCAR4 is linked to metastatic malignant neoplasm in the lymph nodes.